December 4, 2017 Life Science Tools Product Launch

BD Announces New Offerings to Help Customers Deliver Safer, Simpler and Smarter Medication Management

ORLANDO, Fla., Dec. 4, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today revealed several technology innovations to further optimize the entire medication management process at this year’s American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting. In addition to the recent introduction of the BD HealthSight™ platform... Read more

November 30, 2017 Life Science Tools M&A, Partnerships

NuGEN and LGC announce collaboration agreement

London, UK, Nov 30, 2017 LGC and NuGEN have today announced a collaboration agreement for the commercialisation of the Single Primer Enrichment Technology (SPET) and distribution of Allegro Targeted Genotyping reagents for NGS library preparation. This collaboration will benefit customers of both LGC and NuGEN, as it expands options to access the SPET technology through the SeqSNP service in LGC’s global service... Read more

November 28, 2017 Life Science Tools Product Launch

FASTQ Files to Gene Counts Without Advanced Bioinformatics Skills.

ST. LOUIS and VIENNA — 11/28/17 — Partek and Lexogen scientists have joined forces to deliver an easy-to-use analysis pipeline in Partek® Flow® software for data generated by Lexogen’s QuantSeq 3’ Library Prep Kits. QuantSeq is an economical protocol for RNA-Seq gene expression analysis and provides an alternative to microarrays. This pipeline enables Lexogen customers to import raw sequencing files directly into Partek... Read more

November 28, 2017 Clinical Research/Diagn. Life Science Tools PR/Corporate

Bio-Rad Authorizes New $250 Million Share Repurchase Program

HERCULES, Calif — November 28, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced that its board of directors has authorized a new share repurchase program, granting the Company authority to repurchase, on a discretionary basis, up to $250 million of the outstanding... Read more

November 27, 2017 Lab Top-10 Life Science Tools Product Launch

Expanded Genome Editing Tool Kit Supports Every Step in Researchers' Workflow

New cas9 protein and synthetic gRNA strengthen Thermo Fisher Scientific’s portfolio of genome editing products CARLSBAD, Calif., Nov. 27, 2017 /PRNewswire/ — As researchers continue their quest to create more relevant cellular models, they now have access to a comprehensive portfolio of solutions from Thermo Fisher Scientific designed to maximize the performance of their genome... Read more

November 16, 2017 Licensing, IP, and Legal Life Science Tools

Oxford Genetics Licenses SnapFast Expression Vectors to Twist Bioscience

Download PDF November 16, 2017, Oxford, England and San Francisco, Calif. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist... Read more

November 16, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools Product Launch

Edico Genome Announces New Offering: Comprehensive Clinical Genomics Information System

SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology’s 2017 Annual Meeting (AMP), Edico Genome announced a new offering: the comprehensive DRAGEN Clinical Genomics Information System (CGIS). Designed to enable clinical laboratories of all sizes to quickly, simply and efficiently develop sequencing-based laboratory developed tests (LDTs), DRAGEN CGIS harnesses the power of... Read more

November 16, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Edico Genome Partners with Children’s Hospital Los Angeles to Accelerate Diagnoses, Enhance Somatic and Germline Research Initiatives with DRAGEN Bio-IT Platform

SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles (CHLA). The hospital will utilize Edico Genome’s DRAGENTM Bio-IT platform to deliver enhanced patient care and accelerate research initiatives to expand test offerings for children with genetic disorders and cancer. CHLA... Read more

November 15, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools Product Launch

QIAGEN advances precision medicine by automating guidelines on cancer variants in industry-leading QIAGEN Clinical Insight software

First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations Hilden, Germany, and Germantown, Maryland, November 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for... Read more